The main mechanism and function of PrLZ, a newly-discovered PCa-specific oncoprotein, in PCa development deserves further investigations, and the miR-499a/PrLZ axis could be a potential target for eradicating PCa CSCs [103]. This evidence concerns the gene TPD52 and posterior cortical atrophy.